Research graph
References from Timing of revascularisation in patients undergoing high-risk percutaneous coronary intervention and Transcatheter aortic valve implantation: insights from the ASCoP registry. Local targets link to admitted publications; unresolved targets remain external evidence.
Coronary artery disease and TAVI: current evidence on a recurrent issue
2023 · External reference
Transcatheter aortic valve implantation in patients with and without concomitant coronary artery disease: comparison of characteristics and early outcome in the German multicenter TAVI registry
10.1007/s00392-012-0486-5 · 2012 · External reference
Transcatheter aortic valve implantation with complex, high-risk indicated PCI
10.4244/eij-e-25-00011 · 2025 · External reference
Impact of untreated chronic obstructive coronary artery disease on outcomes after transcatheter aortic valve replacement
10.1093/eurheartj/ehae019 · 2024 · External reference
Comparison of different percutaneous revascularisation timing strategies in patients undergoing transcatheter aortic valve implantation
10.4244/eij-d-23-00186 · 2023 · External reference
The effect of coronary artery disease defined by quantitative coronary angiography and SYNTAX score upon outcome after transcatheter aortic valve implantation (TAVI) using the Edwards bioprosthesis
10.4244/eijy14m05_09 · 2015 · External reference
Outcomes of complex, high-risk percutaneous coronary intervention in patients with severe aortic stenosis: the ASCoP registry
10.4244/eij-d-24-00933 · 2025 · External reference
Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research
10.1093/eurheartj/ehaa799 · 2021 · External reference
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium
10.1161/circulationaha.110.009449 · 2011 · External reference
Standardized end point definitions for coronary intervention trials: the academic research Consortium-2 consensus document
10.1161/circulationaha.117.029289 · 2018 · External reference
Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies
10.1002/sim.6607 · 2015 · External reference
Statistical primer: propensity score matching and its alternatives
10.1093/ejcts/ezy167 · 2018 · External reference
Severe aortic stenosis and coronary artery disease
2013 · External reference
2025 ESC/EACTS Guidelines for the management of valvular heart disease
10.1093/eurheartj/ehaf194 · 2025 · External reference
Coronary artery disease and transcatheter aortic valve replacement: JACC state-of-the-art review
10.1016/j.jacc.2019.06.012 · 2019 · External reference
Efficacy and safety of dual antiplatelet therapy after complex PCI
10.1016/j.jacc.2016.07.760 · 2016 · External reference
Coronary cannulation after transcatheter aortic valve replacement: the RE-ACCESS study
10.1016/j.jcin.2020.07.006 · 2020 · External reference
Coronary cannulation following TAVR using self-expanding devices with commissural alignment: the RE-ACCESS 2 study
10.1016/j.jcin.2023.12.015 · 2024 · External reference
The coronary access after TAVI (CAvEAT) study: A prospective registry of CA after TAVR
10.1016/j.jcin.2025.05.002 · 2025 · External reference
Timing and outcomes of percutaneous coronary intervention in patients who underwent transcatheter aortic valve implantation
10.1016/j.amjcard.2020.01.043 · 2020 · External reference
ACTIVATION (PercutAneous coronary inTervention prIor to transcatheter aortic VAlve implantaTION): a randomized clinical trial
10.1016/j.jcin.2021.06.041 · 2021 · External reference
PCI in patients undergoing transcatheter aortic-valve implantation
10.1056/nejmoa2401513 · 2024 · External reference
Deferral of percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation (PRO-TAVI): an investigator-initiated, multicentre, open-label, non-inferiority, randomised controlled trial
10.1016/s0140-6736(26)00308-9 · 2026 · External reference
Timing of PCI in patients undergoing transcatheter aortic-valve implantation
10.1056/nejmoa2606924 · 2026 · External reference
Clinical impact of myocardium at risk in transcatheter aortic valve implantation
10.1161/circinterventions.125.015770 · 2026 · External reference
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trial
10.1016/s0140-6736(18)31714-8 · 2018 · External reference
10.4244/eij-d-22-00958
10.4244/eij-d-22-00958 · 2023 · External reference
